|
Boehringer Ingelheim initiates Phase IIa study of compound acquired from Pharmaxis in debilitating liver disease NASH
|
25 August 2017 |
|
Boehringer Ingelheim achieves good growth in the first half of 2017
|
09 August 2017 |
|
Jardiance® (empagliflozin) analysis reinforces established safety profile
|
06 July 2017 |
|
'More than Systemic Sclerosis: The Inside Story' - patients reveal the unseen impact of lung fibrosis
|
29 June 2017 |
|
Boehringer Ingelheim presents phase III results demonstrating clinical equivalence of adalimumab biosimilar candidate to HUMIRA®
|
15 June 2017 |
|
Boehringer Ingelheim builds Digital Lab "BI X" with focus on innovative digital solutions in healthcare
|
12 June 2017 |
|
Boehringer Ingelheim inaugurates world-class biopharmaceutical manufacturing facility in China
|
16 May 2017 |
|
Boehringer Ingelheim expands collaboration with Vanderbilt University to tackle some of the most difficult-to-treat cancers
|
08 March 2017 |
|
Boehringer Ingelheim and Weill Cornell Medicine announce new collaboration to discover next generation COPD treatments
|
15 February 2017 |
|
Boehringer Ingelheim biosimilar candidate to Humira® accepted for EMA and FDA regulatory review
|
19 January 2017 |
|
Sanofi and Boehringer Ingelheim confirm Closing of business swap
|
04 January 2017 |
|
Nearly 20% of newly diagnosed lung cancer patients tested for EGFR mutations at risk of missing out on personalised treatments for their disease
|
08 December 2016 |
|
Boehringer Ingelheim and China Southeast University collaborate to develop new treatment approaches for hearing loss
|
29 November 2016 |
|
New European study highlights differing priorities in physician's therapy goals when treating advanced lung cancer patients
|
08 November 2016 |
|
Boehringer Ingelheim and SARAH CANNON Research Institute launch strategic collaboration to develop novel immune-oncology therapies
|
04 October 2016 |
|
Saniona and Boehringer Ingelheim sign collaboration agreement in schizophrenia
|
30 August 2016 |
|
Boehringer Ingelheim: Growth in all core businesses
|
05 August 2016 |
|
The European Stroke Organisation and Boehringer Ingelheim launch the "Angels Initiative"
|
21 July 2016 |
|
Boehringer Ingelheim and Lilly announce clinical trial collaboration in metastatic breast cancer
|
13 July 2016 |
|
Boehringer Ingelheim and Harvard scientists establish a research alliance
|
07 June 2016 |